University Medical Center of Southern Nevada
Board of Hospital Trustees
AGENDA ITEM
|
Petitioner: |
Mason Van Houweling, Chief Executive Officer |
Recommendation:
title
Approve the Purchaser-Specific Agreement Form with Vitalant for blood products and services; authorize the Chief Executive Officer to execute the Agreement, future amendments, and extensions; or take action as deemed appropriate. (For possible action)
body
FISCAL IMPACT:
|
Fund #: |
5420.000 |
Fund Name: |
UMC Operating Fund |
|
Fund Center: |
3000999901 |
Funded PGM/Grant: |
N/A |
|
Amount: |
Not-to-Exceed: $8,000,000 annually or $40,000,000 in aggregate |
|
Description: |
Award of Bid 2025-07 UMC 7 Story Tower & Trauma Building Elevator Modernization Project |
|
Additional Comments: |
Bid/RFP/CBE: NRS 450.525 and NRS 450.530. Term: Three Years w/two annual renewal options. Out Clause: Termination for uncured cause; Budget Act/Fiscal Fund out |
BACKGROUND:
This request is to enter into a new agreement with Vitalant to provide blood products and services to UMC. The initial term of this Agreement is three years but could extend to five years via two, separate, one-year options. Accordingly, staff also requests authorization for UMC’s Chief Executive Officer to execute any extension options and future amendments within the not-to-exceed amount of this Agreement should UMC staff deem such beneficial to UMC.
This Agreement is pursuant to UMC’s HealthTrust Purchasing Group (HPG) contract number 37377. HPG is a group purchasing organization (GPO) of which UMC is a member. This request is in compliance with NRS 450.525 and NRS 450.530. A signed sourcing letter from HPG has been included, stating that the pricing was obtained through a competitive bid process.
Vitalant is a Nevada-registered corporation and currently holds a Clark County business license.
UMC’s Director of Laboratory Services has reviewed and recommends approval of this Agreement. This Agreement has been approved as to form by UMC’s Office of General Counsel.
This Agreement was reviewed by the Governing Board Audit and Finance Committee at its February 18, 2026, meeting and recommended for approval by the Governing Board.
The Governing Board at their February 25, 2026, meeting reviewed the Agreement and recommended approval as requested above by the Board of Hospital Trustees.